Original Study| Volume 31, ISSUE 3, P270-273, June 2018

Download started.


Serum 25-Hydroxy Vitamin D Levels in Turkish Adolescent Girls with Polycystic Ovary Syndrome and the Correlation with Clinical/Biochemical Parameters

Published:August 03, 2017DOI:


      Study Objective

      Polycystic ovary syndrome (PCOS) is a common endocrinopathy among female adolescents and young women. The aim of this study was to investigate the relationship between serum 25-hydroxy vitamin D (25[OH] D) levels and metabolic parameters and other characteristics of PCOS and non-PCOS adolescents.


      Case-control study.

      Setting and Participants

      We analyzed 31 girls with PCOS as defined using the Rotterdam criteria and 35 girls were non-PCOS control participants.

      Interventions and Main Outcome Measures

      The serum 25(OH) D level was measured. Anthropometric, clinical, endocrine, and metabolic components were determined in both groups.


      The group with PCOS showed no difference in the level of serum 25(OH) D (14.58 ± 6.15 vs 16.02 ± 7.87; P = .414). In addition to this, no significant correlations were found between serum 25(OH) D levels and endocrine or metabolic parameters in either PCOS patients or control participants.


      There was no difference in the level of serum 25(OH) D between PCOS patients and matched control participants. Vitamin D deficiency was common among the patients as well as in the control participants. Also, we did not find any relationship between serum 25(OH) D levels and clinical or metabolic profiles in the 2 groups.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Pediatric and Adolescent Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • March W.A.
        • Moore V.M.
        • Willson K.J.
        • et al.
        The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.
        Hum Reprod. 2010; 25: 544-51
        • Lucky A.W.
        • Rosenfield R.L.
        • McGuire J.
        • et al.
        Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche.
        J Clin Endocrinol Metab. 1986; 62: 840-848
        • Ghadimi R.
        • Esmaeilzadeh S.
        • Firoozpour M.
        • et al.
        Does vitamin D status correlate with clinical and biochemical features of polycystic ovary syndrome in high school girls?.
        Caspian J Intern Med. 2014; 5: 202-208
        • Van Hooff M.
        • Voorhorst F.J.
        • Kaptein M.B.
        • et al.
        Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at 18 years.
        Hum Reprod. 2004; 19: 383-392
        • Ibanez L.
        • Potau N.
        • Marcos M.V.
        • et al.
        Adrenal hyperandrogenism in adolescent girls with a history of low birthweight and precocious pubarche.
        Clin Endocrinol (Oxf). 2000; 53: 523-527
        • Pereira-Santos M.
        • Costa P.R.
        • Assis A.M.
        • et al.
        Obesity and vitamin D deficiency: a systematic review and meta-analysis.
        Obes Rev. 2015; 16: 341-349
        • Reis J.P.
        • Von Mühlen D.
        • Miller 3rd, E.R.
        • et al.
        Vitamin D status and cardiometabolic risk factors in the United States adolescent population.
        Pediatrics. 2009; 124: 371-379
        • Rodríguez-Rodríguez E.
        • Navia-Lombán B.
        • López-Sobaler A.M.
        • et al.
        Associations between abdominal fat and body mass index on vitamin D status in a group of Spanish schoolchildren.
        Eur J Clin Nutr. 2010; 64: 461-467
        • Vilarrasa N.
        • Maravall J.
        • Estepa A.
        • et al.
        Low 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables.
        J Endocrinol Invest. 2007; 30: 653-658
        • The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
        Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.
        Fertil Steril. 2004; 81: 19-25
        • Fritz M.A.
        • Speroff L.
        Clinical gynecologic endocrinology and infertility. 8th ed. Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia (PA)2011: 533-565
        • Oh J.Y.
        • Sung Y.A.
        • Lee H.J.
        The lipid accumulation product as a useful index for identifying abnormal glucose regulation in young Korean women.
        Diabet Med. 2013; 30: 436-442
        • Bouillon R.
        • Van Schoor N.M.
        • Gielen E.
        • et al.
        Optimal vitamin D status: a critical analysis on the basis of evidence–based medicine.
        Clin Endocrinol Metab. 2013; 98: 1283-1304
        • Keskin M.
        • Kurtoglu S.
        • Kendirci M.
        • et al.
        Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents.
        Pediatrics. 2005; 115: e500-e503
        • Reinehr T.
        • Andler W.
        Changes in the atherogenic risk factor profile according to degree of weight loss.
        Arch Dis Child. 2004; 89: 419-422
        • Valerio G.
        • Licenziati M.R.
        • Iannuzzi A.
        • et al.
        Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy.
        Nutr Metab Cardiovasc Dis. 2006; 16: 279-284
        • Dimartino-Nardi J.
        Premature adrenarche: findings in prepubertal African-American and Caribbean-Hispanic girls.
        Acta Paediatr Suppl. 1999; 88: 67-72
        • Li H.W.
        • Brereton R.E.
        • Anderson R.A.
        • et al.
        Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome.
        Metabolism. 2011; 60: 1475-1481
        • Panidis D.
        • Balaris C.
        • Farmakiotis D.
        • et al.
        Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome.
        Clin Chem. 2005; 51: 1691-1697
        • Kim J.J.
        • Choi Y.M.
        • Chae S.J.
        • et al.
        Vitamin D deficiency in women with polycystic ovary syndrome.
        Clin Exp Reprod Med. 2014; 41: 80-85
        • Wehr E.
        • Trummer O.
        • Giuliani A.
        • et al.
        Vitamin D associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome.
        Eur J Endocrinol. 2011; 164: 741-749
        • Mahmoudi T.
        • Gourabi H.
        • Ashrafi M.
        • et al.
        Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome.
        Fertil Steril. 2010; 93: 1208-1214
        • He C.
        • Lin Z.
        • Robb S.W.
        • et al.
        Serum vitamin D levels and polycystic ovary syndrome: a systematic review and meta-analysis.
        Nutrients. 2015; 7: 4555-4577
        • Jia X.Z.
        • Wang Y.M.
        • Zhang N.
        • et al.
        Effect of Vitamin D on clinical and biochemical parameters in polycystic ovary syndrome women: a meta-analysis.
        J Obstet Gynaecol Res. 2015; 41: 1791-1802
        • Lips P.
        Worldwide status of vitamin D nutrition.
        J Steroid Biochem Mol Biol. 2010; 121: 297-300
        • De Souza S.J.
        • Pereira S.E.
        • Saboya Sobrinho C.J.
        • et al.
        Obesity, related diseases and their relationship with vitamin D deficiency in adolescents.
        Nutr Hosp. 2016; 33: 856-864
        • Holick M.F.
        Vitamin D deficiency.
        N Engl J Med. 2007; 357: 266-281
        • Moran L.J.
        • Misso M.L.
        • Wild R.A.
        • et al.
        Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.
        Hum Reprod Update. 2010; 16: 347-363
        • Hahn S.
        • Haselhorst U.
        • Tan S.
        • et al.
        Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome.
        Exp Clin Endocrinol Diabetes. 2006; 114: 577-583